Objective:To explore the effect of empowerment-authorized health management on the rehabilitation,self-efficacy and quality of life in patients with non-ST-segment elevation acute coronary syndrome(NSTE-ACS)after per-cutaneous coronary intervention(PCI).Methods:This randomized controlled study enrolled 100 NSTE-ACS patients ad-mitted in the First Affiliated Hospital of Xinjiang Medical University between January 2021 and June 2023.Patients were randomly divided into control group(n=50,routine nursing)and intervention group(n=50,empowerment-authorized health management).Both groups were intervened for 6 months.The scores of heart health self-efficacy and self-man-agement(HH-SESM)scale,China questionnaire of quality of life in patients with cardiovascular diseases(CQQC),cardi-ac function indexes,serum levels of N terminal pro brain natriuretic peptide(NT-proBNP)and cardiac troponin I(cTnI),6min walking distance(6MWD),satisfaction and incidence of adverse events were compared between the two groups.Re-sults:Compared to patients in the control group after nursing,those in the intervention group had significant higher HH-SESM total score[(79.34±6.18)points vs.(62.33±6.17)points],CQQC total score[(116.24±7.13)points vs.(83.27±7.11)points],left ventricular ejection fraction(LVEF)[(59.32±4.36)％vs.(51.22±4.63)％],6min walk-ing distance(6MWD)[(363.61±12.51)m vs.(299.13±13.54)m]and satisfaction(86.96％vs.68.09％)(P＜0.05 or＜0.01),and significant lower left ventricular end-systolic diameter(LVESd)[(32.44±3.91)mm vs.(39.25±3.61)mm],left ventricular end-diastolic diameter(LVEDd)[(41.23±4.18)mm vs.(46.17±5.41)mm],NT-proBNP[(6.16±1.58)pg/ml vs.(12.51±3.27)pg/ml]and cTnI[(2.65±0.62)ng/ml vs.(5.60±1.81)ng/ml](P＜0.001 all).The incidence of adverse events in the intervention group(4.35％)was significantly lower than that of control group(19.15％,P=0.027).Conclusion:Empowerment-authorized health management mode was beneficial to the recovery of cardiac function and significantly improved self-efficacy and quality of life in patients with non-ST-segment elevation a-cute coronary syndrome.

Objective:To explore the effect of empowerment-authorized health management on the rehabilitation,self-efficacy and quality of life in patients with non-ST-segment elevation acute coronary syndrome(NSTE-ACS)after per-cutaneous coronary intervention(PCI).Methods:This randomized controlled study enrolled 100 NSTE-ACS patients ad-mitted in the First Affiliated Hospital of Xinjiang Medical University between January 2021 and June 2023.Patients were randomly divided into control group(n=50,routine nursing)and intervention group(n=50,empowerment-authorized health management).Both groups were intervened for 6 months.The scores of heart health self-efficacy and self-man-agement(HH-SESM)scale,China questionnaire of quality of life in patients with cardiovascular diseases(CQQC),cardi-ac function indexes,serum levels of N terminal pro brain natriuretic peptide(NT-proBNP)and cardiac troponin I(cTnI),6min walking distance(6MWD),satisfaction and incidence of adverse events were compared between the two groups.Re-sults:Compared to patients in the control group after nursing,those in the intervention group had significant higher HH-SESM total score[(79.34±6.18)points vs.(62.33±6.17)points],CQQC total score[(116.24±7.13)points vs.(83.27±7.11)points],left ventricular ejection fraction(LVEF)[(59.32±4.36)％vs.(51.22±4.63)％],6min walk-ing distance(6MWD)[(363.61±12.51)m vs.(299.13±13.54)m]and satisfaction(86.96％vs.68.09％)(P＜0.05 or＜0.01),and significant lower left ventricular end-systolic diameter(LVESd)[(32.44±3.91)mm vs.(39.25±3.61)mm],left ventricular end-diastolic diameter(LVEDd)[(41.23±4.18)mm vs.(46.17±5.41)mm],NT-proBNP[(6.16±1.58)pg/ml vs.(12.51±3.27)pg/ml]and cTnI[(2.65±0.62)ng/ml vs.(5.60±1.81)ng/ml](P＜0.001 all).The incidence of adverse events in the intervention group(4.35％)was significantly lower than that of control group(19.15％,P=0.027).Conclusion:Empowerment-authorized health management mode was beneficial to the recovery of cardiac function and significantly improved self-efficacy and quality of life in patients with non-ST-segment elevation a-cute coronary syndrome.